Variant report
Variant | esv3395077 |
---|---|
Chromosome Location | chr6:1674190-1674952 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs534561802 | chr6:1674210-1674211 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs146978585 | chr6:1674232-1674233 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs534547946 | chr6:1674253-1674254 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs6912355 | chr6:1674286-1674287 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs116302763 | chr6:1674288-1674289 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs557016173 | chr6:1674291-1674292 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs573643778 | chr6:1674300-1674301 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs543312233 | chr6:1674334-1674335 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs559747057 | chr6:1674342-1674343 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs76308573 | chr6:1674394-1674395 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs557811016 | chr6:1674474-1674475 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs4552776 | chr6:1674504-1674505 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs545319834 | chr6:1674510-1674511 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs573742190 | chr6:1674511-1674512 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs6936424 | chr6:1674518-1674519 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs147628199 | chr6:1674529-1674530 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs149109901 | chr6:1674546-1674547 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs567339196 | chr6:1674575-1674576 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs530003433 | chr6:1674597-1674598 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs572642626 | chr6:1674602-1674603 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs191460516 | chr6:1674604-1674605 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs538257156 | chr6:1674635-1674636 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs565876093 | chr6:1674640-1674641 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs143164453 | chr6:1674651-1674652 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs558011063 | chr6:1674682-1674683 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs77829407 | chr6:1674729-1674730 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs564868534 | chr6:1674763-1674764 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs201112863 | chr6:1674791-1674792 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs532284936 | chr6:1674792-1674793 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs536167658 | chr6:1674794-1674795 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs577706110 | chr6:1674796-1674797 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs537157123 | chr6:1674851-1674852 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs148274002 | chr6:1674852-1674853 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs141136326 | chr6:1674857-1674858 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs542302647 | chr6:1674869-1674870 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs552926563 | chr6:1674876-1674877 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs9392318 | chr6:1674920-1674921 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs12525117 | chr6:1674948-1674949 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs56833272 | chr6:1674949-1674950 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs34359136 | chr6:1674950-1674951 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Prader-willi syndrome | 20588305 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Developmental delay | 19490664 | CNVD |
Cancer | 21183584 | CNVD |
Multiple Epiphyseal Dysplasia | 20877625 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Glaucoma | 18694899 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 20164920 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21364760 | CNVD |
Lung cancer | 18438408 | CNVD |
Bladder cancer | 21909424 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 20164919 | CNVD |
Gastric cancer | 16891809 | CNVD |
Ovarian cancer | 21781307 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Autism | 22495311 | CNVD |
Autism | 21448237 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:1633000-1679800 | Weak transcription | Rectal Mucosa Donor 31 | rectum |
2 | chr6:1651600-1679200 | Weak transcription | Sigmoid Colon | Sigmoid Colon |
3 | chr6:1651800-1678400 | Weak transcription | Aorta | Aorta |
4 | chr6:1667800-1687800 | Weak transcription | Fetal Intestine Small | intestine |
5 | chr6:1671400-1679600 | Weak transcription | HepG2 | liver |
6 | chr6:1671600-1679600 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
7 | chr6:1671800-1678600 | Weak transcription | Esophagus | oesophagus |
8 | chr6:1672600-1674600 | Enhancers | Primary neutrophils fromperipheralblood | blood |
9 | chr6:1672600-1680400 | Weak transcription | Fetal Thymus | thymus |
10 | chr6:1673200-1678400 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
11 | chr6:1673200-1678800 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
12 | chr6:1673400-1678600 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
13 | chr6:1673600-1678600 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
14 | chr6:1674000-1678600 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
15 | chr6:1674000-1679200 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
16 | chr6:1674000-1679800 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
17 | chr6:1674600-1677400 | Weak transcription | Primary neutrophils fromperipheralblood | blood |